Adaptive Phage Therapeutics is Drug Discovery in United States that focus on Provider business. Founded in 2016. They cover business area such as Provider, therapeutic service, multi-drug resistant pathogenic bacteria, clinical and therapeutic technology, phage, patient-specific bacterial infection, medical researcher, multi-drug resistant bacteria.
2016
( 8 years old in 2024 )
Provider
-
708 Quince Orchard Road
Suite 205
Gaithersburg, MD 20878
United States
Private
Providertherapeutic servicemulti-drug resistant pathogenic bacteriaclinical and therapeutic technologyphagepatient-specific bacterial infectionmedical researchermulti-drug resistant bacteria
* We use standard office opening hours in near Adaptive Phage Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Adaptive Phage Therapeutics is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Adaptive Phage Therapeutics business is focusing on Provider.
Adaptive Phage Therapeutics headquarter office and corporate office address is located in 708 Quince Orchard Road Suite 205 Gaithersburg, MD 20878 United States.
Adaptive Phage Therapeutics was founded in United States.
In 2024, Adaptive Phage Therapeutics is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Adaptive Phage Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
